GLP-1 drugs now required to have new warning labels for rare side effect of weight loss
The new warning says that the drugs can decrease blood flow to the optic nerve and can lead to sudden vision loss.
Watch CBS News
The new warning says that the drugs can decrease blood flow to the optic nerve and can lead to sudden vision loss.
Popular weight loss drugs such as Ozempic and Wegovy could prevent breast cancer, preliminary research from Penn Medicine shows. Reporter Stephanie Stahl talked to the lead researcher about the study.
Research shows that some people are thinking about skipping their weight loss medication for the holiday, but doctors say that's not a good idea.
President Trump on Thursday announced a deal to drastically lower the price of weight loss drugs for some Americans.
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
A growing number of people are taking weight loss drugs. While they work for most people, results tend to vary. This research indicates that could be because of a person's family history.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research.
Brandon Downey, a New Jersey nurse, said the drug Wegovy has helped him lose weight and overcome an alcohol addiction.
The high price of some popular weight loss drugs is at the center of a congressional committee on Tuesday with a pharmaceutical executive in the hot seat. Stephanie Stahl reports more on the price concerns.
Incorrect dose calculations have resulted in patients administering 5 to 10 times more of the medication than drugmakers intended.
Oprah Winfrey is donating her shares in WeightWatchers and stepping down from the board, another blow to weight-loss companies that have struggled with the rise of drugs like Wegovy and Ozempic - which Oprah said she uses, though she has not named one specifically.
Published Saturday in the New England Journal of Medicine, the study included more than 17,600 participants aged 45 and older who had preexisting heart conditions.
A new study from drugmaker Novo Nordisk found that its weight-loss drug Wegovy can reduce the risk of heart problems in people without diabetes, which could change the way doctors treat certain heart patients.